Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and PCV-13 Vaccine Response in Older Adults
NCT03713801Phase 1Completed
- Sponsor
- UT Health San Antonio
- Start
- Jan 2019
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liquid metformin (Aspargo Labs) (2 arms), sponsored by UT Health San Antonio. Primary endpoint: Change in antibody responses to PCV13 at 8 weeks. Started Jan 2019; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
Beyond the preview
Go deeper on NCT03713801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03713801.